Work

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.1018

Authors: J. A. Cauley, S. Martino, E. Barrett-Connor, T. J. Powles, J. L. Mershon, D. Disch, R. J. Secrest, S. R. Cummings

Institutions: Eli Lilly (United States), University of Pittsburgh, California Pacific Medical Center, University of California San Diego

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594988018

Cites:

Cited by: 7

Related to: 10